85.58
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $85.58, with a volume of 3.82M.
It is down -0.37% in the last 24 hours and up +3.46% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$85.99
Open:
$85.655
24h Volume:
3.82M
Relative Volume:
0.32
Market Cap:
$213.80B
Revenue:
$63.43B
Net Income/Loss:
$16.42B
P/E Ratio:
13.19
EPS:
6.4861
Net Cash Flow:
$14.72B
1W Performance:
-3.52%
1M Performance:
+3.46%
6M Performance:
+8.20%
1Y Performance:
-21.92%
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MRK
Merck Co Inc
|
85.59 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
![]()
LLY
Lilly Eli Co
|
822.17 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
190.39 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
231.78 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
129.72 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
May-14-25 | Downgrade | Citigroup | Buy → Neutral |
Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
Jan-08-25 | Downgrade | Truist | Buy → Hold |
Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
Dec-10-24 | Resumed | BofA Securities | Buy |
Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
Oct-17-24 | Initiated | Bernstein | Mkt Perform |
Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
Nov-09-23 | Initiated | Deutsche Bank | Buy |
Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Oct-20-23 | Upgrade | UBS | Neutral → Buy |
Jul-14-23 | Initiated | HSBC Securities | Hold |
Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Mar-06-23 | Initiated | Jefferies | Buy |
Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
Nov-18-22 | Initiated | Credit Suisse | Outperform |
Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
Jun-06-22 | Resumed | SVB Leerink | Outperform |
Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
Dec-17-21 | Initiated | Goldman | Buy |
Dec-16-21 | Initiated | Daiwa Securities | Neutral |
Dec-13-21 | Downgrade | UBS | Buy → Neutral |
Dec-09-21 | Initiated | Wells Fargo | Overweight |
Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
Nov-01-21 | Upgrade | Argus | Hold → Buy |
Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-27-21 | Resumed | Truist | Buy |
May-20-21 | Downgrade | Argus | Buy → Hold |
Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
Nov-10-20 | Resumed | Bernstein | Outperform |
Sep-29-20 | Initiated | Berenberg | Hold |
Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Feb-27-20 | Initiated | Barclays | Overweight |
Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
Oct-17-19 | Resumed | BofA/Merrill | Neutral |
Aug-16-19 | Initiated | SVB Leerink | Outperform |
Jul-03-19 | Initiated | Mizuho | Buy |
May-28-19 | Initiated | Goldman | Neutral |
May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
Oct-16-18 | Reiterated | Citigroup | Buy |
Oct-09-18 | Resumed | Guggenheim | Buy |
Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck: An Undervalued Stock In An Expensive Market - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Earns Neutral Rating from Citigroup - MarketBeat
NorthRock Partners LLC Buys 6,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Verdence Capital Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Sequoia Financial Advisors LLC Has $23.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Stack Financial Management Inc Sells 4,025 Shares of Merck & Co., Inc. $MRK - MarketBeat
Johnson Investment Counsel Inc. Sells 11,817 Shares of Merck & Co., Inc. $MRK - MarketBeat
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - The Motley Fool
GW Henssler & Associates Ltd. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Legal Advantage Investments Inc. Acquires 5,040 Shares of Merck & Co., Inc. $MRK - MarketBeat
SPC Financial Inc. Sells 4,577 Shares of Merck & Co., Inc. $MRK - MarketBeat
OFI Invest Asset Management Has $56.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Orca Investment Management LLC Buys Shares of 18,466 Merck & Co., Inc. $MRK - MarketBeat
Cwm LLC Purchases 140,163 Shares of Merck & Co., Inc. $MRK - MarketBeat
Advocate Group LLC Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Makes New $3.20 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Vanguard Personalized Indexing Management LLC - MarketBeat
Merck & Co. Inc. (MRK): Billionaire D.E. Shaw Is Bullish On This Stock Right Now - MSN
Merck & Co., Inc. $MRK Shares Purchased by waypoint wealth counsel - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by GFS Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Wealth Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Position Boosted by Drucker Wealth 3.0 LLC - MarketBeat
Eastern Bank Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Agate Pass Investment Management LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Unloaded Rep. Val T. Hoyle - MarketBeat
Robertson Stephens Wealth Management LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Ramirez Asset Management Inc. Sells 14,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments - Benzinga
JB Capital LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Cascade Investment Group Inc. Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
Commerzbank Aktiengesellschaft FI Has $15.70 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Vontobel Holding Ltd. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Hold (C-) Rating at Weiss Ratings - MarketBeat
Blair William & Co. IL Sells 68,932 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Mainstay Capital Management LLC ADV - MarketBeat
Live Oak Investment Partners Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Leo Wealth LLC Purchases 15,115 Shares of Merck & Co., Inc. $MRK - MarketBeat
US Bancorp DE Sells 115,264 Shares of Merck & Co., Inc. $MRK - MarketBeat
Insight Inv LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
5,920 Shares in Merck & Co., Inc. $MRK Bought by Allegiance Financial Group Advisory Services LLC - MarketBeat
Armstrong Fleming & Moore Inc Takes $628,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Tectonic Advisors LLC Buys 21,124 Shares of Merck & Co., Inc. $MRK - MarketBeat
Values Added Financial LLC Takes $248,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Narwhal Capital Management Sells 26,064 Shares of Merck & Co., Inc. $MRK - MarketBeat
Optas LLC Has $817,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Capital Management Associates Inc Purchases New Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Maryland State Retirement & Pension System - MarketBeat
Sax Wealth Advisors LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE:MRK) Operational Moves Impact Dow Jones Index - Kalkine Media
MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Chart Expert Says Merck (MRK) Has More Upside – Here’s Why - Yahoo Finance
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Merck Co Inc Stock (MRK) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Guindo Chirfi | Chief Marketing Officer |
Aug 04 '25 |
Option Exercise |
79.29 |
36,903 |
2,926,039 |
107,409 |
Smart Dalton E. III | SVP Fin. - Global Controller |
May 03 '25 |
Option Exercise |
83.18 |
2,050 |
170,519 |
10,127 |
Smart Dalton E. III | SVP Fin. - Global Controller |
Apr 30 '25 |
Option Exercise |
84.71 |
464 |
39,305 |
8,242 |
Smart Dalton E. III | SVP Fin. - Global Controller |
May 02 '25 |
Option Exercise |
83.26 |
381 |
31,722 |
8,464 |
Romanelli Joseph | President, Human Health Int?l |
May 02 '25 |
Option Exercise |
83.26 |
2,262 |
188,334 |
24,061 |
Romanelli Joseph | President, Human Health Int?l |
Apr 30 '25 |
Option Exercise |
84.71 |
2,063 |
174,757 |
22,816 |
Larson Betty D | EVP, Chief HR Officer |
Apr 30 '25 |
Option Exercise |
84.71 |
11,350 |
961,458 |
11,350 |
Smart Dalton E. III | SVP Fin. - Global Controller |
Apr 25 '25 |
Option Exercise |
58.08 |
5,000 |
290,400 |
12,040 |
Smart Dalton E. III | SVP Fin. - Global Controller |
Apr 25 '25 |
Sale |
82.76 |
4,262 |
352,723 |
7,778 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):